At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 55 enrolled
Drug / intervention
CPP-115 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Double-blind, Placebo-controlled, Single Ascending Dose Study of the Safety, Tolerability and Pharmacokinetics of CPP-115 Solution Administered Orally to Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating CPP-115 and Placebo for Cocaine Dependency. Completed, enrolled 55 participants across 1 site.
Detailed Summary
Primary Objective: • To evaluate the safety and tolerability of ascending single oral doses of CPP-115 Secondary Objective: • To determine the pharmacokinetic profiles of CPP-115 following administration of a ascending single oral doses
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependency
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
First PostedDec 2011
Primary CompletionJun 2012
Study CompletionAug 2012
TodayJul 2026
First PostedDec 16, 2011
Enrollment StartDec 1, 2011
Primary CompletionJun 1, 2012
Study CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.5 years ago
Interventions
CPP-115drug
Appropriate amount of drug substance will be dissolved in juice within 3 hours of dosing.
Placebodrug
An equal volume of water mixed with juice will be administered.